Literature DB >> 31759197

Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise.

Weslie Y Khoo1, Benjamin J Chrisfield1, Sudathip Sae-Tan1, Joshua D Lambert2.   

Abstract

We have shown that combination treatment with decaffeinated green tea extract (GTE) and voluntary exercise (Ex) reduces obesity and insulin resistance in high-fat (HF)-fed mice to a greater extent than either treatment alone. Here, we investigated the effects of GTE-, Ex- or the combination on the development of obesity-related NAFLD. Male C57BL/6 J mice were treated for 16 weeks with HF diet (60% energy from fat), HF supplemented with 7.7 g GTE/kg, HF plus access to a voluntary running wheel, or the combination. We found that treatment of mice with the combination mitigated the development of HF-induced NAFLD to a greater extent than either treatment alone. Combination-treated mice had lower plasma alanine aminotransferase (92% lower) and hepatic lipid accumulation (80% lower) than HF-fed controls: the effect of the single treatments was less significant. Mitigation of NAFLD was associated with higher fecal lipid and nitrogen levels. Combination treated, but not singly treated mice, had higher hepatic expression of genes related to mitochondrial biogenesis (sirtuin 1 [59%]; peroxisome proliferator-activated receptor γ coactivator 1α [42%]; nuclear respiratory factor 1 [38%]; and transcription factor B1, mitochondrial [89%]) compared to the HF-fed controls. GTE-, Ex-, and the combination-treatment groups also had higher hepatic expression of genes related to cholesterol synthesis and uptake, but the combination was not better than the single treatments. Our results suggest the combination of GTE and Ex can effectively mitigate NAFLD. Future studies should determine if the combination is additive or synergistic compared to the single treatments.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (−)-Epigallocatechin-3-gallate; Green tea extract; Nonalcoholic fatty liver disease; Voluntary exercise

Year:  2019        PMID: 31759197      PMCID: PMC6995759          DOI: 10.1016/j.jnutbio.2019.108262

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  46 in total

1.  Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations.

Authors:  K Schneider; J Oltmanns; M Hassauer
Journal:  Regul Toxicol Pharmacol       Date:  2004-06       Impact factor: 3.271

2.  Interaction between Tea Polyphenols and Bile Acid Inhibits Micellar Cholesterol Solubility.

Authors:  Kazuki Ogawa; Sayumi Hirose; Satoshi Nagaoka; Emiko Yanase
Journal:  J Agric Food Chem       Date:  2015-12-22       Impact factor: 5.279

3.  Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice.

Authors:  Yeyi Gu; Shan Yu; Jong Yung Park; Kevin Harvatine; Joshua D Lambert
Journal:  J Nutr Biochem       Date:  2013-12-31       Impact factor: 6.048

4.  Caffeine is protective in patients with non-alcoholic fatty liver disease.

Authors:  A Birerdinc; M Stepanova; L Pawloski; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-11-07       Impact factor: 8.171

5.  Green Tea Polyphenols Mitigate Gliadin-Mediated Inflammation and Permeability in Vitro.

Authors:  Charlene B Van Buiten; Joshua D Lambert; Ryan J Elias
Journal:  Mol Nutr Food Res       Date:  2018-05-28       Impact factor: 5.914

6.  Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study.

Authors:  Ryuichiro Sakata; Toru Nakamura; Takuji Torimura; Takato Ueno; Michio Sata
Journal:  Int J Mol Med       Date:  2013-09-20       Impact factor: 4.101

7.  Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome.

Authors:  Arpita Basu; Nancy M Betts; Afework Mulugeta; Capella Tong; Emily Newman; Timothy J Lyons
Journal:  Nutr Res       Date:  2013-01-30       Impact factor: 3.315

8.  Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status.

Authors:  Manami Inoue; Norie Kurahashi; Motoki Iwasaki; Taichi Shimazu; Yasuhito Tanaka; Masashi Mizokami; Shoichiro Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

10.  Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.

Authors:  Haejoe Park; Virendar K Kaushik; Scarlet Constant; Marc Prentki; Ewa Przybytkowski; Neil B Ruderman; Asish K Saha
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  3 in total

Review 1.  Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.

Authors:  Hang-Yu Li; Ren-You Gan; Ao Shang; Qian-Qian Mao; Quan-Cai Sun; Ding-Tao Wu; Fang Geng; Xiao-Qin He; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-03-01       Impact factor: 6.543

2.  Regular exercise combined with ferulic acid exhibits antiobesity effect and regulates metabolic profiles in high-fat diet-induced mice.

Authors:  Ou Wang; Nanhai Zhang; Chao Han; Jian Huang
Journal:  Front Nutr       Date:  2022-07-27

Review 3.  The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Authors:  Reem Abou Assi; Ibrahim M Abdulbaqi; Chan Siok Yee
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.